41 results
DEFM14A
EAR
Eargo Inc
16 Jan 24
Proxy related to merger
4:46pm
and corporate governance requirements of NASDAQ.
(ii) The Company maintains disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e
DEFA14A
EAR
Eargo Inc
1 Dec 23
Additional proxy soliciting materials
4:03pm
“Directors, Executive Officers and Corporate Governance” included in the Company’s most recent Annual Report filed on Form 10-K for the fiscal year ended
PREM14A
EAR
Eargo Inc
21 Nov 23
Preliminary proxy related to merger
4:41pm
in all material respects with the applicable listing and corporate governance requirements of NASDAQ.
(ii) The Company maintains disclosure controls
8-K
EX-2.1
awit41n
30 Oct 23
Entry into a Material Definitive Agreement
5:24pm
8-K
qwyufa7u xii822mafp
7 Dec 22
Eargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority Shareholder
4:19pm
8-K
EX-99.1
ro0z3xff2412bkv1a22
7 Dec 22
Eargo Announces Strategic Additions to Board of Directors Following Patient Square Capital Becoming New Majority Shareholder
4:19pm
PRER14A
1vedw9a
26 Aug 22
Preliminary revised proxy
4:39pm
PRE 14A
610dhghr
12 Aug 22
Preliminary proxy
4:07pm
8-K
EX-10.4
b227r6obae8jqroed1ua
27 Jun 22
Eargo Strengthens Financial Position with up to $125 Million Strategic Investment from Patient Square Capital
7:23am